NASDAQ: XERS Xeris Biopharma Holdings, Inc. 8-K

Xeris Biopharma reports Q1 2026 earnings and business highlights

Filed May 7, 2026 · Period ending May 7, 2026 · ~1 min read

Key Changes

  • medium

    Xeris issued its first quarter 2026 financial results and operational updates through a press release on May 7, 2026. The actual financial figures and business metrics are contained in the attached exhibit rather than the 8-K body.

See the full narrative summary and section-by-section diff — create a free account to read more. Takes 30 seconds.

Partner

Trade XERS commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 8, 2026 4:19 PM